Secukinumab-induced Raynaud's phenomenon: first report in the literature

Basit Öğe Kaydı
dc.authoridŞenol Kobak / 0000-0001-8270-640Xen_US
dc.authorscopusidŞenol Kobak / 12782228700
dc.authorwosidŞenol Kobak / AAO-2482-2020
dc.contributor.authorKobak, Şenol
dc.date.accessioned2020-08-30T20:06:17Z
dc.date.available2020-08-30T20:06:17Z
dc.date.issued2020
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.descriptionKOBAK, SENOL/0000-0001-8270-640Xen_US
dc.description.abstractSecukinumab is an IL-17A antagonist that has proven efficacy in the treatment of patients with ankylosing spondylitis (AS) and psoriatic arthritis. Side effects of the drug include infections, skin rashes, and allergic reactions. Raynaud's phenomenon (RP), a vasospastic syndrome and an important feature of different connective tissue diseases, is not an expected finding in AS patients. This article reports the development of secukinumab-related RP in a 35-year-old female patient with AS. Treatment with secukinumab was continued and RP was treated with low-dose aspirin and a calcium-channel blocker.en_US
dc.identifier.citationKobak, S. (2020). Secukinumab-induced Raynaud’s phenomenon: first report in the literature. THERAPEUTIC ADVANCES IN DRUG SAFETY, 11. https://doi.org/10.1177/2042098620905976en_US
dc.identifier.doi10.1177/2042098620905976en_US
dc.identifier.issn2042-0986en_US
dc.identifier.issn2042-0994en_US
dc.identifier.pmid32128108en_US
dc.identifier.scopus2-s2.0-85081413541en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.1177/2042098620905976
dc.identifier.urihttps://hdl.handle.net/20.500.12713/454
dc.identifier.volume11en_US
dc.identifier.wosWOS:000517239700001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorKobak, Şenolen_US
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.ispartofTherapeutic Advances In Drug Safetyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnkylosing Spondylitisen_US
dc.subjectRaynaud's Phenomenonen_US
dc.subjectSecukinumaben_US
dc.titleSecukinumab-induced Raynaud's phenomenon: first report in the literatureen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
H69.pdf
Boyut:
527.2 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/ Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu